Home › NDC Lookup › Ingredients › Rugby Zinc Oxide 20% › 00536-1316-98
Rugby Zinc Oxide 20% 20 g/100g Ointment — NDC 00536-1316-98 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Rugby Zinc Oxide 20% 20 g/100g Ointment — NDC 0536-1316-98 (Billing 00536-1316-98)

by Rugby Laboratories · 12 JAR in 1 CASE / 454 g in 1 JAR

This is a package of Rugby Zinc Oxide 20% 20 g/100g Ointment from Rugby Laboratories, marketed since Mar 2021 and currently FDA-listed; retail pharmacies pay about $0.0154 per g (NADAC).

NDC 00536-1316-98
🏷️ FDA NDC (as labeled) 0536-1316-98 billing pads the labeler segment with a zero
This package
Contains454 g in 1 jar Cost per g$0.0154 NADAC Per package$83.90 / 5448 g Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.0386/unit — full pricing hub ↓
Product page 00536-1316-25 Also comes in: 72 tubes 0536-1316-25 72 tubes 0536-1316-28
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0536-1316-98 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1316 product · 98 package
Package marketed since
Mar 1, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0305361316259, 0305361316983, 0305361316280
Medicaid fills, this package
9,426 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1316-98
Product NDC 0536-1316
11-digit billing NDC 00536131698
NCPDP billing unit GM — per gram (weight)
RxCUI 198911
UNII SOI2LOH54Z
UPC 0305361316259, 0305361316983, 0305361316280
Application # M016
SPL Set ID b96f6697-c912-7d62-e053-2a95a90a9f5b
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-03-01
Route TOPICAL
Dosage form OINTMENT
Substance ZINC OXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90971020004210
GPI class Zinc Oxide
GCN Seq No 005576
GCN 22080
HICL code 002361
Ingredient (HICL) Zinc Oxide
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L3
Therapeutic class — intermediate (HIC2) Protectives
HIC3 code L3A
Therapeutic class — specific (HIC3) Protectives
AHFS code 84:24.12.00
AHFS class Basic Ointments And Protectants
FDB label name ZINC OXIDE 20% OINTMENT
FDB brand name Zinc Oxide
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 005576
  • GCN: 22080
  • GPI-14 (Medi-Span): 90971020004210
  • HICL (First Databank): 002361
  • AHFS class code: 84:24.12.00
  • RxCUI (RxNorm): 198911
Why two NDCs? The FDA registers this code as 0536-1316-98 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1316-98. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ZINC OXIDE 20% OINTMENT Ingredient Zinc Oxide
🧪 What is this product?

Rugby Zinc Oxide 20% is an over-the-counter ointment applied to the skin. Zinc oxide is a topical ingredient commonly used in products meant to protect skin and provide a moisture barrier. This product is marketed as an OTC monograph drug, meaning it is made according to FDA category rules rather than as an individually reviewed application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.015 $83.90 / 5448 g
Medicaid paysCMS SDUD · 12 mo $0.0386 $210.29 / 5448 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Mar 2022 Oct 2022 Mar 2026 Sep 2026 $0.016 $0.014
Flat over the last 19 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00536-1316-25 0536-1316-25 Main listing 72 TUBE in 1 CASE / 60 g in 1 TUBE $0.0611 / g $264.08 2021-03-01 — Active
00536-1316-28 0536-1316-28 72 TUBE in 1 CASE / 30 g in 1 TUBE $0.0772 / g $166.67 2021-03-01 — Active
00536-1316-98 You're viewing this 12 JAR in 1 CASE / 454 g in 1 JAR $0.0154 / g $84.01 2021-03-01 — Active

This pack has the lowest per-g cost of the 3 priced pack sizes ($0.0154 NADAC).

This pack accounts for about 24% of this product's recent Medicaid fills; the largest share goes to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 12 jar in 1 case / 454 g in 1 jar.
What NDC number is used to bill for this package of Rugby Zinc Oxide 20% 20 g/100g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Zinc Oxide 20% 20 g/100gthis 00536-1316-98 Rugby 12 jars $0.015 — Availability likely —
Zinc Oxide 20 g/100g 68001-0533-50 BluePoint 454 g $0.015 — Availability likely —
Leader Zinc Oxide 200 mg/g 70000-0334-01 Cardinal 454 g $0.015 — Availability likely —
Good Neighbor Pharmacy Skin Protectant .2 g/g 46122-0676-46 AMERISOURCE 1 tube $0.036 — Availability likely +136%
Zinc Oxide 20 g/100g 68001-0532-45 BluePoint 1 tube $0.077 — Availability likely +400%
Nivagen Zinc Oxide 200 mg/g 75834-0170-01 Nivagen 28.4 g $0.105 — Availability likely +580%
Sheffield Zinc Oxide 200 mg/g 11527-0065-34 Sheffield 1 tube — — FDA listed —
CAREALL Zinc Oxide .2 g/g 51824-0032-03 New 28 g — — FDA listed —
ProCure Zinc Oxide 20 g/100g 55681-0017-01 Twin 28.3 g — — FDA listed —
Procure 20 g/100g 55681-0304-03 TWIN 28.3 g — — FDA listed —
Endit Zinc Oxide Skin Protectant 20 g/100g 64068-0402-01 Endit 454 g — — FDA listed —
Endit zinc oxide skin protection 200 mg/g 64068-0500-01 EndIt 56.7 g — — FDA listed —
Zinc Oxide .2 g/g 64772-0201-01 Derma 453.6 g — — FDA listed —
Zinc Oxide 200 mg/g 67777-0223-02 Dynarex 1 tube — — FDA listed —
Zinc Oxide 20% .2 g/g 68016-0159-02 Pharmacy 1 tube — — FDA listed —
dabur 20 g/100g 68747-3040-03 Dabur 28 g — — FDA listed —
Zinc Oxide 20% .2 g/g 69396-0021-02 Trifecta 1 tube — — FDA listed —
Zinc Oxide 20% .2 g/g 69396-0086-02 Trifecta 1 tube — — FDA listed —
zinc oxide 20% 20 g/100g 69452-0450-58 Bionpharma 425 g — — FDA listed —
Zinc Oxide 20 g/100g 69771-0109-38 Geri-Gentle 1 tube — — FDA listed —
CVS Zinc Oxide 200 mg/g 69842-0065-34 CVS 1 tube — — FDA listed —
Medpura Zinc Oxide 20% 20 g/100g 71399-0245-02 Akron 1 tube — — FDA listed —
Zinc Oxide 20% .2 g/g 83324-0052-01 Chain 1 tube — — FDA listed —
Zinc Oxide Pharma 200 mg/g 84387-0001-01 ALLIED 56.6 g — — FDA listed —
ElixirZincoCare 20 g/100g 84546-0004-01 ELIXIR 1 tube — — FDA listed —
Zinc Oxide Skin Protectant 20 g/100g 87236-0007-16 Aldermed 454 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Mar 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

ShapeFreeform
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedMar 2021
Product typeHuman Otc Drug
Portfolio149 products on file

More NDCs from Rugby Laboratories labeler code 00536

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 15 words ▾

Uses • Dries the oozing and weeping of poison: • Ivy • Oak • Sumac

⏱️ Dosage and Administration 10 words ▾

Directions For poison ivy, oak, and sumac: apply as needed.

⚠️ Warnings 83 words ▾

Warnings For External Use Only When using this product • Do not get into eyes • Do not use over large areas of the body Stop use and ask a doctor if • The condition worsens • Symptoms last more than 7 days or clear up and occur again within a few days • If you are allergic to any of these ingredients Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 6 words ▾

Active Ingredient Zinc Oxide 20% w/w

🧪 Inactive Ingredients 13 words ▾

Inactive Ingredients Cetomacrogol 1000, Cetostearyl Alcohol, Light Mineral Oil, White Soft Paraffin (Petrolatum)

🎯 Purpose 3 words ▾

Purpose Skin Protectant

📄 When Using This Product 20 words ▾

When using this product • Do not get into eyes • Do not use over large areas of the body

📄 Stop Use and Ask a Doctor If 38 words ▾

Stop use and ask a doctor if • The condition worsens • Symptoms last more than 7 days or clear up and occur again within a few days • If you are allergic to any of these ingredients

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 14 words ▾

Other Information • Store at room temperature between 15°-30°C (59°-86°F) • Avoid excessive heat

📄 Questions or Comments 4 words ▾

Questions and Comments? 1-800-645-2158

📄 Package Label / Principal Display Panel 12 words ▾

Label CR-371060 Label CR-371060_BX_MASTER

Label CR-371076 Label CR-371076_IN_MASTER

Label CR-371067 Label CR-371067_BX_MASTER

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
9.4K
Units reimbursed last 4 qtrs
2.5M
Gross reimbursed last 4 qtrs
$95.3K
Avg / prescription
$10.11
Avg / unit
$0.0386
Latest quarter Q4 2025
2.7KRx
Medicaid pays / g
$0.0386
gross reimbursed
vs
NADAC / g
$0.0154
acquisition cost
=
Spread
+$0.0232
+151% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
58% FFS 42% MCO
Fee-for-service · 5,444 Rx Managed care · 3,982 Rx
State Medicaid map
Alaska: no data reported AK Maine: 23,953 units · 1,717 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 49,519 units · 863 per 100k residents MN Wisconsin: 2,571 units · 43.5 per 100k residents WI Michigan: 5,017 units · 50.0 per 100k residents MI New York: 1,048,124 units · 5,355 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 26,728 units · 631 per 100k residents OR Nevada: 27,354 units · 856 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 175,709 units · 1,400 per 100k residents IL Indiana: 111,194 units · 1,620 per 100k residents IN Ohio: 130,762 units · 1,110 per 100k residents OH Pennsylvania: 118,913 units · 917 per 100k residents PA New Jersey: 52,026 units · 560 per 100k residents NJ Massachusetts: 142,250 units · 2,032 per 100k residents MA California: 33,227 units · 85.3 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 21,264 units · 1,075 per 100k residents NE Missouri: no data reported MO Kentucky: 136,495 units · 3,016 per 100k residents KY West Virginia: no data reported WV Virginia: 46,486 units · 533 per 100k residents VA Maryland: 13,212 units · 214 per 100k residents MD Connecticut: no data reported CT Rhode Island: 5,873 units · 536 per 100k residents RI Arizona: 19,188 units · 258 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: 5,038 units · 164 per 100k residents AR Tennessee: 32,312 units · 453 per 100k residents TN North Carolina: 42,345 units · 391 per 100k residents NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 196,021 units · 643 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
43.55,355
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 5,355 /100k
2 Kentucky 3,016 /100k
3 Massachusetts 2,032 /100k
4 Maine 1,717 /100k
5 Indiana 1,620 /100k
6 Illinois 1,400 /100k
7 Ohio 1,110 /100k
8 Nebraska 1,075 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
72 tubes00536-1316-25 17,170 Rx · $153,958
72 tubes00536-1316-28 12,770 Rx · $97,610
12 jars this page00536-1316-98 9,426 Rx · $95,277
Drug total (last 4 qtrs): 39,366 Rx · 4,144,903 units · $346,846 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 00536-1315-43 · Rugby 00536-1317-83 · RUGBY →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.